Sugi Predict

Sugi Predict / Compounds / SCHEMBL770120

SCHEMBL770120

SCHEMBL770120

O=S(=O)(c1ccc(F)cc1)N(c1cc(Br)cnc1Cl)S(=O)(=O)c1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PSEN1 P49768 2/20 0.39
▸ PSEN2 P49810 2/20 0.39
▸ APH1B Q8WW43 2/20 0.39
▸ NCSTN Q92542 2/20 0.39
▸ APH1A Q96BI3 2/20 0.39
▸ PSENEN Q9NZ42 2/20 0.39
▸ PIK3CA P42336 4/20 0.39
▸ MTOR P42345 2/20 0.39
▸ EGFR P00533 1/20 0.38
▸ BACE1 P56817 1/20 0.37
▸ PIK3CD O00329 2/20 0.37
▸ NFE2L2 Q16236 2/20 0.36
▸ KEAP1 Q14145 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ PTGS2 P35354 1/20 0.35
▸ KCNA5 P22460 1/20 0.35
▸ ALPL P05186 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926027 0.86 PSEN1 (0.52) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1558035 0.86 CYP3A4 (0.48) PIK3CAEGFRBACE1PIK3CDKMT2A
SCHEMBL12276604 0.84 PIK3CD (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL24522222 0.82 EGFR (0.36) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL770195 0.74 LPL (0.40) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL117014 0.74 ALDH1A1 (0.37) PIK3CAPIK3CDKMT2AALPLALDH1A1
SCHEMBL115237 0.72 PIK3CD (0.62) PIK3CAMTORPIK3CD
SCHEMBL12274035 0.72 PIK3CD (0.62) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1650420 0.72 ALDH1A1 (0.43) PIK3CDKMT2AALPLALDH1A1NPSR1
SCHEMBL769676 0.71 PIK3CA (0.66) PIK3CAMTORPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8729074-B2 Inhibitors of PI3 kinase AMGEN INC. (US) 2014-05-20 — — US disclosed
US-8729074-B2 Inhibitors of PI3 kinase AMGEN INC. (US) 2014-05-20 — — US disclosed
EP-2183232-B1 PI3 KINASE MODULATORS AND METHODS OF USE AMGEN INC (US) 2013-03-06 — — EP disclosed
US-20120071474-A1 INHIBITORS OF PI3 KINASE AMGEN INC. (US) 2012-03-22 — — US disclosed
US-7928140-B2 Benzothiazole PI3 kinase modulators for cancer treatment AMGEN INC. (US) 2011-04-19 — — US disclosed
WO-2010108074-A2 INHIBITORS OF PI3 KINASE AMGEN INC. (US) 2010-09-23 — — WO disclosed
EP-2183232-A2 PI3 KINASE MODULATORS AND METHODS OF USE Amgen, Inc (US) 2010-05-12 — — EP disclosed
US-20090054405-A1 PI3 kinase modulators and methods of use AMGEN INC. (US) 2009-02-26 — — US disclosed
WO-2009017822-A2 PI3 KINASE MODULATORS AND METHODS OF USE AMGEN INC. (US) 2009-02-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054405-A1 PI3 kinase modulators and methods of use PIK3CA, PIK3C2A, PIK3C2B PSEN1 3556/4885PSEN2 3719/4885APH1B 4311/4885
US-20120071474-A1 INHIBITORS OF PI3 KINASE PIK3CA, PIK3CD, PIK3CG PSEN1 2392/4885PSEN2 2074/4885APH1B 4611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.